Medicenna Therapeutics Corp. Profit Loss Before Tax
Medicenna Therapeutics Corp. (MDNAF) reported Profit Loss Before Tax of -CAD 10.05 million for the 12-month period ending 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Notes
ifrs-full:ProfitLossBeforeTax · last filed 2023-06-27
| Period end | Profit Loss Before Tax 12 month |
|---|---|
| 2023-03-31 | -10.05M CAD 20-F · filed 2023-06-27 |
| 2022-03-31 | -22.58M CAD 20-F · filed 2023-06-27 |
| 2021-03-31 | -17.29M CAD 20-F · filed 2023-06-27 |
| 2020-03-31 | -8.28M CAD 20-F · filed 2022-06-22 |